Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2021 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 7.20B | 7.20B | 5.36B | 8.88B | 4.81B | 8.24B |
Gross Profit | 2.03B | 2.12B | 1.27B | 1.69B | 1.62B | 2.59B |
EBITDA | 239.17M | 239.17M | -286.38M | 788.73M | 628.82M | 1.22B |
Net Income | 13.99M | 13.99M | -704.90M | 421.25M | 248.67M | 794.96M |
Balance Sheet | ||||||
Total Assets | 6.20B | 6.20B | 6.23B | 7.07B | 3.54B | 5.71B |
Cash, Cash Equivalents and Short-Term Investments | 199.82M | 199.82M | 542.00K | 1.55M | 3.39M | 471.86M |
Total Debt | 3.18B | 3.18B | 3.16B | 2.29B | 790.47M | 1.42B |
Total Liabilities | 3.97B | 3.97B | 4.03B | 4.13B | 1.80B | 3.19B |
Stockholders Equity | 2.23B | 2.23B | 2.20B | 2.94B | 1.74B | 2.52B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 393.38M | -672.58M | -1.21B | 791.42M | 122.07M |
Operating Cash Flow | 0.00 | 441.27M | -553.92M | -881.55M | 843.47M | 269.71M |
Investing Cash Flow | 0.00 | -166.20M | 17.96M | -221.67M | -55.69M | -198.25M |
Financing Cash Flow | 0.00 | -274.81M | 534.96M | 632.91M | -788.09M | 397.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | ₹11.97B | 30.30 | ― | 0.41% | 64.35% | ― | |
64 Neutral | ₹17.21B | 37.31 | ― | 0.22% | 9.24% | 2.10% | |
64 Neutral | ₹10.92B | 4.29 | ― | ― | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
44 Neutral | ₹2.92B | 0.15 | ― | ― | -99.98% | -101.75% |
Khaitan Chemicals & Fertilizers Ltd. announced the appointment of M/s Ritesh Gupta & Co. as Secretarial Auditors for a five-year term starting from FY 2025-26, pending shareholder approval. This decision, recommended by the Audit Committee and approved by the Board of Directors, underscores the company’s commitment to robust corporate governance and compliance.
Khaitan Chemicals & Fertilizers Ltd. announced its audited financial results for the quarter and financial year ending March 31, 2025, revealing no profit and an elongated working capital cycle, leading to a decision not to recommend any dividend for the year. The company also made several key appointments, including new secretarial, cost, and internal auditors, and noted the completion of tenure for a Whole-Time Director, indicating a strategic focus on strengthening its financial and operational governance.